MJ Acquisition Indigestion Hits Bottom Line, But Bio-Rad Hungry for More M&A | GenomeWeb

Despite suffering from bottom-line indigestion relating to the acquisition of MJ GeneWorks in August, Bio-Rad Laboratories has negotiated a $200 million line of credit to go after even more acquisitions, the company said in a conference call last week after the release of its fourth-quarter financials.

In the quarter, which ended Dec. 31, the company sold $200 million of 6.125-percent senior subordinated notes due 2014 in a private offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.